Reduction of HIV-1 Load in Semen During Follow-up Study of RV144 Vaccine Trial Boosts Interest for Novel Correlates of Immune Protection in Genital Mucosa

Spetz, Anna-Lena; Chiodi, Francesca
April 2013
Journal of Infectious Diseases;Apr2013, Vol. 207 Issue 8, p1189
Academic Journal
In this article, the author discusses the findings of a study conducted by researcher S. Rerks-Ngarm and colleagues on developing a vaccine for the prevention of HIV-1 infection. The author notes that the study reveals lower viral loads in the semen of recipients of HIV-1 infection preventing vaccine during the RV144 trial conducted in Thailand and expresses caution regarding the efficacy of the RV144 vaccine for the prevention of HIV-1 infection.


Related Articles

  • Dr. Michael Keefer of the HIV Vaccine Trials Unit on the Step Study. Jordan, Susan // Empty Closet;Dec2007/Jan2008, Issue 408, p6A 

    An interview with Doctor Michael Keefer, head of the HIV Vaccine Trials Unit at the University of Rochester, New York, on the Step Study of the Merck Ad5-HIV vaccine is presented. He cites that the positive result of the study was a decrease in viral load among vaccine recipients who...

  • Vaccine study pipeline faces ethical and other challenges.  // AIDS Alert;Oct2007, Vol. 22 Issue 10, p1 

    The article focuses on the challenges that arise concerning studies of HIV vaccines.

  • Vaccine claims to have rid HIV virus in animals. Taylor, Billy // Pink Paper;5/6/2011, p29 

    The article provides information on a U.S. medical study which developed an experimental HIV vaccines that claims to remove traces of the virus.

  • Group looks for vaccine-study candidates. REHWINKEL, CHASSE // Windy City Times;9/30/2009, Vol. 24 Issue 52, p6 

    The article reports on the search of the research group Project WISH for participants of an HIV vaccine study.

  • HIV vaccine trials begin in Oxford. Fazal, Akil // BMJ: British Medical Journal (International Edition);09/09/2000, Vol. 321 Issue 7261, p591 

    Reports on the September 2000 launch of an AIDS vaccine clinical trial sponsored by the International AIDS Vaccine Initiative. Overview of international HIV vaccine development; Details of the synthetically manufactured vaccine being testing against an African strain of HIV; Outlook for the...

  • HIV vaccine-induced seropositivity common in clinical trials.  // Reactions Weekly;7/31/2010, Issue 1312, p4 

    The article discusses research study done on the frequency of vaccine-induced seropositivity/reactivity (VISP) in human immunodeficiency virus (HIV) vaccine trial participants by C. J. Cooper and colleagues, published in the July 21, 2010 issue of the "Journal of the American Medical Association."

  • Challenges in the development of an HIV-1 vaccine. Barouch, Dan H. // Nature;10/2/2008, Vol. 455 Issue 7213, p613 

    The development of a safe and effective human immunodeficiency virus (HIV)-1 vaccine is a critically important global health priority. Despite recent advances in our understanding of HIV-1 pathogenesis and immunology, however, major scientific obstacles remain. Prototype HIV-1 vaccine candidates...

  • Mucosal correlates of isolated HIV semen shedding during effective antiretroviral therapy. Sheth, P M; Yi, T J; Kovacs, C; Kemal, K S; Jones, R B; Osborne, B; Pilon, R; la Porte, C; Ostrowski, M; Mazzulli, T; Burger, H; Weiser, B; Kaul, R // Mucosal Immunology (1933-0219);May2012, Vol. 5 Issue 3, p248 

    Effective antiretroviral therapy (ART) suppresses the blood HIV RNA viral load (VL) below the level of detection. However, some individuals intermittently shed HIV RNA in semen despite suppression of viremia, a phenomenon termed 'isolated HIV semen shedding (IHS)'. In a previously reported...

  • World Bank task force push/pulls AIDS vaccines. Dove, Alan // Nature Biotechnology;Sep99, Vol. 17 Issue 9, p846 

    Reports on the evaluation of various interventions that would help ensure the profitability of an effective vaccine for AIDS by a task force of the World Bank. Provision of financial aids to public health initiatives by the World Bank; Economic and administrative hinderances faced by AIDS...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics